Heart and liver disease share hidden drivers, opening new treatment paths

Researchers have identified overlapping biological mechanisms linking two increasingly common chronic diseases—heart failure with preserved function and metabolic liver disease. The discovery could reshape how doctors diagnose and treat both conditions, potentially reducing hospitalizations and expanding markets for therapies targeting shared pathways rather than isolated organs.

Originaltitel: HFpEF and MASLD: converging mechanisms and clinical implications